In this study, we investigated the association between FGF-23 and cardiac remodeling and subclinical cardiac disease measured by CMR in a large cohort of patients with type 2 diabetes and normal or mildly impaired kidney function. The gene discussed is FGF23; the disease is type 2 diabetes mellitus.